Rock Springs Capital Management LP Kymera Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

$2.51 Billion
Q4 2024

A detailed history of Rock Springs Capital Management LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,034,137 shares of KYMR stock, worth $38.1 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

1,034,137

Previous 1,049,386 1.45%

Holding current value

$38.1 Million

Previous $49.7 Million 16.24%

% of portfolio

1.66%

Previous 1.69%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$39.06 - $51.84 $595,625 - $790,508	-15,249 Reduced 1.45%	1,034,137 $41.6 Million
Q3 2024 Nov 14, 2024	SELL	$30.16 - $52.4 $3.46 Million - $6 Million	-114,587 Reduced 9.84%	1,049,386 $49.7 Million
Q2 2024 Aug 14, 2024	SELL	$29.85 - $39.42 $10.7 Million - $14.1 Million	-358,265 Reduced 23.54%	1,163,973 $34.7 Million
Q4 2023 Feb 14, 2024	BUY	$10.97 - $26.84 $196,220 - $480,087	17,887 Added 1.19%	1,522,238 $38.8 Million
Q3 2023 Nov 14, 2023	BUY	$13.9 - $23.88 $233,520 - $401,184	16,800 Added 1.13%	1,504,351 $20.9 Million
Q2 2023 Aug 14, 2023	BUY	$22.4 - $34.92 $5.81 Million - $9.05 Million	259,172 Added 21.1%	1,487,551 $34.2 Million
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $14,904 - $23,250	600 Added 0.05%	1,228,379 $36.4 Million
Q4 2022 Feb 14, 2023	BUY	$19.57 - $30.92 $3.54 Million - $5.6 Million	181,036 Added 17.3%	1,227,779 $30.6 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $5.66 Million - $9.28 Million	270,864 Added 34.91%	1,046,743 $22.8 Million
Q2 2022 Aug 15, 2022	BUY	$14.13 - $42.55 $282,656 - $851,170	20,004 Added 2.65%	775,879 $15.3 Million
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $487,492 - $893,230	13,810 Added 1.86%	755,875 $32 Million
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $456,077 - $599,087	9,138 Added 1.25%	742,065 $47.1 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $5.09 Million - $7.09 Million	106,400 Added 16.98%	732,927 $43.1 Million
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $147,630 - $246,762	4,750 Added 0.76%	626,527 $30.4 Million
Q1 2021 May 17, 2021	SELL	$35.64 - $85.46 $3.28 Million - $7.87 Million	-92,088 Reduced 12.9%	621,777 $24.2 Million
Q4 2020 Feb 16, 2021	BUY	$28.07 - $87.83 $109,473 - $342,537	3,900 Added 0.55%	713,865 $44.3 Million
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $18.5 Million - $23.6 Million	709,965 New	709,965 $22.9 Million

Others Institutions Holding KYMR

# of Institutions

185

Shares Held

65.5M

Call Options Held

49.6K

Put Options Held

17K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.02B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Account

Rock Springs Capital Management LP Kymera Therapeutics, Inc. Transaction History